[Endovascular treatment for acute ischemic stroke]

Area of Science:

• Neurology
• Interventional Cardiology
• Vascular Surgery

Background:

• The efficacy of endovascular treatment (ET) for acute ischemic stroke has been a subject of ongoing research and debate.
• Recent evidence suggests a clear clinical benefit for ET within approximately 8 hours of stroke onset, particularly when administered alongside intravenous thrombolysis.
• Factors such as early initiation and performance by experienced teams enhance the positive effects of ET.

Purpose of the Study:

• To summarize the current understanding of endovascular treatment benefits for acute ischemic stroke.
• To highlight the importance of timely intervention and specialized teams in optimizing ET outcomes.
• To discuss the evolving landscape of ET techniques and their impact on stroke care organization.

Main Methods:

• Review of recent studies and clinical trials on endovascular treatment for acute ischemic stroke.
• Analysis of factors influencing treatment efficacy, including time to treatment and team expertise.
• Description of current endovascular techniques, such as stent-retriever thrombectomy and thromboaspiration.

Main Results:

• Endovascular treatment demonstrates significant clinical benefit in acute ischemic stroke patients up to approximately 8 hours post-onset.
• The combination of ET with intravenous thrombolysis shows enhanced positive effects.
• Early initiation of ET and performance by experienced teams are critical for maximizing patient outcomes.

Conclusions:

• Endovascular treatment is a highly efficient therapy for acute ischemic stroke.
• Organizing stroke care networks is crucial to ensure rapid access to ET for all eligible patients.
• The efficiency of ET necessitates streamlined protocols for prompt administration.